Taltz (Ixekizumab)

Taltz (Ixekizumab) is a biologic medicine that suppresses the immune system in order to treat psoriatic arthritis and psoriasis.

Taltz works by blocking a signalling protein (called a cytokine) named interleukin-17 (IL-17). IL-17 regulates the body's immune system and is related to its inflammatory response.

Taking Taltz

Taltz is available as a subcutaneous (under the skin) injection that can be administered at home.

The manufacturer of Taltz offers a support program to Canadian patients that are prescribed the medication:

Patient support program enrolment forms

Important Tests and Risks

Science

Safety

Drug Identification Number (DIN)

02455102

02455110